Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese

  • 23 Accesses

  • 2 Citations

Summary

Twenty patients with essential hypertension were given 400 mg acebutolol once daily for 24 weeks. In order to study if side effects resembling the “Practolol syndrome” developed, ocular effects were sought and antinuclear antibody (ANA) in blood was assessed before and after treatment. ANA was negative both before and after the study in 17 patients; in one patient ANA was positive, but the titre (1:10) was low and did not change during the study. Acebutolol produced no undesirable effects on cornea, conjunctiva or lens. During acebutolol treatment, tear secretion was reduced but tear lysozyme concentration was not significantly altered. Overall, acebutolol had no undesirable action similar to the practolol-induced syndrome, nor did it cause such common clinical ocular symptoms such as dry or gritty eyes.

This is a preview of subscription content, log in to check access.

References

  1. Booth RJ, Willson JD, Bullock JY (1982)β-Adrenergic receptor blockers and antinuclear antibodies in hypertension. Clin Pharmacol Ther 31: 555–558

  2. Cody RJ, Calabrese LH, Clough JD, Tarazi RC, Bravo EL (1979) Development of antinuclear antibodies during acebutolol therapy. Clin Pharmacol Ther 25: 800–805

  3. Cubey RB, Taylor SH (1975) Ocular reaction to propranolol and resolution on continued treatment with different beta-blocking drug. Br Med J 4: 327–328

  4. Felix RH, Ive FA, Dahl MGC (1974) Cutaneous and ocular reactions to practolol. Br Med J 4: 321–324

  5. Friou GI (1957) Clinical application of lupus serum-nucleoprotein reaction using fluorescent antibody technique. J Clin Invest 36: 890

  6. Mackie IA, Seal DV, Pescod JM (1977) Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction. Br J Ophthalmol 61: 354–359

  7. Raftery EB, Denman AM (1973) Systemic lupus erythematosus syndrome induced by practolol. Br Med J 2: 452–455

  8. Richardson PJ, Tee DEH, Oram S (1975) Oculocutaneous reactions to beta-blocking drugs. Br Med J 4: 648

  9. Shapiro A, Kimchi A, Gotsman MS, Lewis BS (1980) Ocular effects of acebutolol and propranolol. Met Ped Ophthalmol 4: 87–88

  10. Wright P (1975) Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J 1: 595–598

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sekine, K., Takahashi, M., Ogata, E. et al. Antihypertensive therapy with a single daily dose of acebutolol in essential hypertension, response and ophthalmological assessment in the Japanese. Eur J Clin Pharmacol 28, 709–711 (1985). https://doi.org/10.1007/BF00607921

Download citation

Key words

  • acebutolol
  • hypertension
  • antinuclear antibody
  • practolol syndrome
  • ocular examination